世界の感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Infectious Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3147 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗菌、抗真菌薬、抗ウイルス薬）、用途別市場規模（病院＆クリニック、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・感染症治療の市場動向 ・企業の競争状況、市場シェア ・感染症治療の種類別市場規模（抗菌、抗真菌薬、抗ウイルス薬） ・感染症治療の用途別市場規模（病院＆クリニック、小売薬局） ・感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Roche、Pfizer、GlaxoSmithKline、AstraZeneca、Novartis、Sanofi、Mylan） ・結論

Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients.

Market Analysis and Insights: Global Infectious Disease Treatment Market
The global Infectious Disease Treatment market size is projected to reach US$ 68510 million by 2026, from US$ 47390 million in 2019, at a CAGR of 5.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Treatment market.

Global Infectious Disease Treatment Scope and Market Size
Infectious Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibacterial
Antifungal Drugs
Antiviral Drugs

Segment by Application
Hospitals & Clinics
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Roche
Pfizer
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi
Mylan

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibacterial
1.2.3 Antifungal Drugs
1.2.4 Antiviral Drugs
1.3 Market by Application
1.3.1 Global Infectious Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Infectious Disease Treatment Market Perspective (2016-2027)
2.2 Infectious Disease Treatment Growth Trends by Regions
2.2.1 Infectious Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Treatment Industry Dynamic
2.3.1 Infectious Disease Treatment Market Trends
2.3.2 Infectious Disease Treatment Market Drivers
2.3.3 Infectious Disease Treatment Market Challenges
2.3.4 Infectious Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Treatment Players by Revenue
3.1.1 Global Top Infectious Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Treatment Revenue
3.4 Global Infectious Disease Treatment Market Concentration Ratio
3.4.1 Global Infectious Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Treatment Revenue in 2020
3.5 Infectious Disease Treatment Key Players Head office and Area Served
3.6 Key Players Infectious Disease Treatment Product Solution and Service
3.7 Date of Enter into Infectious Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Treatment Breakdown Data by Type
4.1 Global Infectious Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Infectious Disease Treatment Breakdown Data by Application
5.1 Global Infectious Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Infectious Disease Treatment Market Size (2016-2027)
6.2 North America Infectious Disease Treatment Market Size by Type
6.2.1 North America Infectious Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease Treatment Market Size by Type (2016-2027)
6.3 North America Infectious Disease Treatment Market Size by Application
6.3.1 North America Infectious Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Treatment Market Size by Application (2016-2027)
6.4 North America Infectious Disease Treatment Market Size by Country
6.4.1 North America Infectious Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Infectious Disease Treatment Market Size (2016-2027)
7.2 Europe Infectious Disease Treatment Market Size by Type
7.2.1 Europe Infectious Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Infectious Disease Treatment Market Size by Application
7.3.1 Europe Infectious Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Treatment Market Size by Country
7.4.1 Europe Infectious Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Infectious Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Infectious Disease Treatment Market Size (2016-2027)
9.2 Latin America Infectious Disease Treatment Market Size by Type
9.2.1 Latin America Infectious Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease Treatment Market Size by Application
9.3.1 Latin America Infectious Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Treatment Market Size by Country
9.4.1 Latin America Infectious Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Infectious Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Infectious Disease Treatment Introduction
11.1.4 Merck Revenue in Infectious Disease Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Infectious Disease Treatment Introduction
11.2.4 Roche Revenue in Infectious Disease Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Infectious Disease Treatment Introduction
11.3.4 Pfizer Revenue in Infectious Disease Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Infectious Disease Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Infectious Disease Treatment Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Infectious Disease Treatment Introduction
11.5.4 AstraZeneca Revenue in Infectious Disease Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Infectious Disease Treatment Introduction
11.6.4 Novartis Revenue in Infectious Disease Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Infectious Disease Treatment Introduction
11.7.4 Sanofi Revenue in Infectious Disease Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Infectious Disease Treatment Introduction
11.8.4 Mylan Revenue in Infectious Disease Treatment Business (2016-2021)
11.8.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Infectious Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibacterial
Table 3. Key Players of Antifungal Drugs
Table 4. Key Players of Antiviral Drugs
Table 5. Global Infectious Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Infectious Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Infectious Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Infectious Disease Treatment Market Share by Regions (2016-2021)
Table 9. Global Infectious Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Infectious Disease Treatment Market Share by Regions (2022-2027)
Table 11. Infectious Disease Treatment Market Trends
Table 12. Infectious Disease Treatment Market Drivers
Table 13. Infectious Disease Treatment Market Challenges
Table 14. Infectious Disease Treatment Market Restraints
Table 15. Global Infectious Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Infectious Disease Treatment Market Share by Players (2016-2021)
Table 17. Global Top Infectious Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Treatment as of 2020)
Table 18. Ranking of Global Top Infectious Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Infectious Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Infectious Disease Treatment Product Solution and Service
Table 22. Date of Enter into Infectious Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Infectious Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Infectious Disease Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Infectious Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Infectious Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Infectious Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Infectious Disease Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Infectious Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Infectious Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Infectious Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Infectious Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Infectious Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Infectious Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Infectious Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Infectious Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Infectious Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Infectious Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Infectious Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Infectious Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Infectious Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Infectious Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Infectious Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Infectious Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Infectious Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Infectious Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Infectious Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Infectious Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Infectious Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Infectious Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Infectious Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Infectious Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Infectious Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Infectious Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Infectious Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Infectious Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Infectious Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Infectious Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Infectious Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Infectious Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Infectious Disease Treatment Product
Table 65. Merck Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Infectious Disease Treatment Product
Table 70. Roche Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Infectious Disease Treatment Product
Table 75. Pfizer Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Infectious Disease Treatment Product
Table 80. GlaxoSmithKline Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Infectious Disease Treatment Product
Table 85. AstraZeneca Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Infectious Disease Treatment Product
Table 90. Novartis Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Infectious Disease Treatment Product
Table 95. Sanofi Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in Infectious Disease Treatment Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibacterial Features
Figure 3. Antifungal Drugs Features
Figure 4. Antiviral Drugs Features
Figure 5. Global Infectious Disease Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Infectious Disease Treatment Report Years Considered
Figure 9. Global Infectious Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Infectious Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Infectious Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Infectious Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Infectious Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Infectious Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Infectious Disease Treatment Revenue in 2020
Figure 16. Global Infectious Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Infectious Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Infectious Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Infectious Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Infectious Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Infectious Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Infectious Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Infectious Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Infectious Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Infectious Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Infectious Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Infectious Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Infectious Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Infectious Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Infectious Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Infectious Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Infectious Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Infectious Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Infectious Disease Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---